Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of culture method of hepatitis E virus and preparation method of inactivated vaccine

A technology for hepatitis E virus and hepatitis E, which is applied in the field of culture methods and the preparation of inactivated vaccines, and can solve the problems of no vaccine sales, and the protection properties need to be further evaluated.

Active Publication Date: 2021-09-14
KUNMING UNIV OF SCI & TECH
View PDF23 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although Xiamen University developed the world's first HEV genetically engineered vaccine "Yikoning" for HEV gene 1 in 2012, it is different from the main epidemic genotype 4 in my country, and there is still no commercial vaccine on the market.
In addition, since the recombinant vaccine only expresses part of the capsid protein of HEV genotype 1, its protective effect on genotype 4, which is mainly prevalent in my country, needs further evaluation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of culture method of hepatitis E virus and preparation method of inactivated vaccine
  • A kind of culture method of hepatitis E virus and preparation method of inactivated vaccine
  • A kind of culture method of hepatitis E virus and preparation method of inactivated vaccine

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0034] In the preparation method of hepatitis E inactivated vaccine of the present invention:

[0035] Step (a) The cell matrix is ​​Vero cells, the cell culture medium is DMEM medium containing 10% fetal bovine serum, and the culture temperature is usually 35.5-37.5°C.

[0036] The medium in step (b) is DMEM medium containing 2% fetal bovine serum, and the culture temperature is usually 35.5-37.5°C.

[0037] The preparation of the vaccine from the purified virus in step (d) can be carried out using conventional methods in the art, for example, the following method can be used: first, the cells selected in step (b) are repeatedly frozen and thawed at -60°C to -80°C for 3-5 times, Obtain virus-cell culture suspension. Then centrifuge at 8000rmp for 30-50min, and collect the supernatant. Concentrate with 10% PEG (molecular weight 6,000) and 0.4M NaCl solution, centrifuge at 10,000 rpm for 50-80 min, discard the supernatant, and collect the precipitate. After suspending the co...

Embodiment 1

[0039] Embodiment 1: the culture method of hepatitis E virus strain KM01

[0040] (a) The virus was isolated from feces of pigs acutely infected with hepatitis E, and was confirmed to be hepatitis E virus through identification of biological characteristics.

[0041] The specific separation method is:

[0042] Take feces from pigs acutely infected with hepatitis E in a 50ml centrifuge tube, add DEPC water and stir at 12000rmp, centrifuge at 4°C for 15min, take the supernatant and filter it through 0.45um and 0.22um microporous filters respectively, and then contain 400U / mL penicillin at a ratio of 1:1000 and 1000U / mL streptomycin double antibody solution, and treated at 4°C for 2 hours to obtain a virus suspension, which was confirmed to be hepatitis E virus by biological characteristics identification.

[0043] (b) Blind passage on Vero cells was adapted for 6 passages and still had a high virus titer (>10 7 ).

[0044] (c) Gradual reduction of culture time during culture ad...

Embodiment 2

[0048] Embodiment 2: the preparation of hepatitis E inactivated vaccine

[0049] Take out the Vero cells from the liquid nitrogen container, centrifuge at 1000rmp for 10min, discard the original preservation solution, add DMEM medium containing 10% fetal bovine serum, culture at 37°C until the cells grow into a monolayer, wash with PBS, trypsinize, Add the above-mentioned medium and continue to subculture until enough cells are obtained.

[0050] When the above cells were cultured at a concentration of 106 / ml, the Hepatitis E virus strain KM01 obtained in Example 1 was added to the pH 7 medium, and cultured at 37° C. for 7 days. After the culture period expired, the cells were repeatedly frozen and thawed three times at -80°C to obtain a virus-cell culture suspension. Then centrifuge at 8000rmp for 30min, and collect the supernatant. Concentrate with 10% PEG (molecular weight 6000) and 0.4M NaCl solution, centrifuge at 10000 rpm for 60 min, discard the supernatant, and colle...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for cultivating hepatitis E virus, and also discloses a method for preparing the inactivated vaccine. The virus can stably proliferate on Vero cells, and animal experiments have confirmed that the virus strain has good immunogenicity and can be used as a virus seed for vaccine production. Using the virus to produce the hepatitis E inactivated vaccine is not only more reliable in terms of safety, but also has good immunogenicity and protective effect, and is an ideal strain for producing the hepatitis E inactivated vaccine.

Description

technical field [0001] The invention relates to the technical field of hepatitis virus, in particular to a method for cultivating hepatitis E virus and a preparation method for an inactivated vaccine thereof. Background technique [0002] Hepatitis E Virus (HEV) is a viral hepatitis pathogen that is transmitted through the fecal-oral route and seriously endangers human health. At present, about one-third of the world's population has been infected with HEV, and the mortality rate of pregnant women infected with HEV is as high as 20%-25%. According to a 2015 WHO report, nearly 20.1 million people were infected with HEV in nine regions of Asia and Africa alone, and the annual death toll reached 300,000, of which 70,000 died from severe hepatitis caused by HEV infection and caused 5,200 fetal deaths. China is one of the areas with a high incidence of hepatitis E. In 1986, a large-scale outbreak occurred in Xinjiang, resulting in 119,280 cases of infection and 707 deaths. The ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N7/00C12N7/06A61K39/29A61K39/39A61P31/14C12R1/93
Inventor 黄芬何秋霞纪汉斌禹文海
Owner KUNMING UNIV OF SCI & TECH